Related references
Note: Only part of the references are listed.Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis
Hongning Jia et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2023)
Exploring the synergic mechanism of Ligusticum striatum DC. and borneol in attenuating BMECs injury and maintaining tight junctions against cerebral ischaemia based on the HIF-1?/VEGF signalling pathway
Xiaoxiong Song et al.
JOURNAL OF ETHNOPHARMACOLOGY (2023)
Captopril alleviates oxidative damage in diabetic retinopathy
Xiang Gao et al.
LIFE SCIENCES (2022)
Peptides derived from sea cucumber accelerate cells proliferation and migration for wound healing by promoting energy metabolism and upregulating the ERK/AKT pathway
Zhihong Zheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy
Lingli Zhou et al.
JCI INSIGHT (2021)
ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK
Joanne M. Munck et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Emerging roles of PLCγ1 in endothelial biology
Dongying Chen et al.
SCIENCE SIGNALING (2021)
Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis
Xue Dong et al.
THERANOSTICS (2021)
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus A Scientific Statement From the American Heart Association
Suzanne Arnold et al.
CIRCULATION (2020)
ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials
Yaru Zhang et al.
DRUGS (2020)
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer
Ying Shen et al.
CANCER CELL (2020)
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
A novel compound DBZ ameliorates neuroinflammation in LPS-stimulated microglia and ischemic stroke rats: Role of Akt(Ser473)/GSK3β (Ser9)-mediated Nrf2 activation
Sha Liao et al.
REDOX BIOLOGY (2020)
Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Asghar Fallah et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis
Xiaozhong Huang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Human Olfactory Bulb Neural Stem Cells (Hu-OBNSCs) Can Be Loaded with Paclitaxel and Used to Inhibit Glioblastoma Cell Growth
Hany E. Marei et al.
PHARMACEUTICS (2019)
Contribution of Angiogenesis to Inflammation and Cancer
Dolores Aguilar-Cazares et al.
FRONTIERS IN ONCOLOGY (2019)
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Chloe J. Peach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Esculetin Inhibits VEGF-Induced Angiogenesis Both In Vitro and In Vivo
Sung Lyea Park et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2016)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Myc and cell cycle control
Gabriel Bretones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway
Qian Yin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Calpastatin Counteracts Pathological Angiogenesis by Inhibiting Suppressor of Cytokine Signaling 3 Degradation in Vascular Endothelial Cells
Takuro Miyazaki et al.
CIRCULATION RESEARCH (2015)
Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis
Sang Hun Lee et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2015)
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
Ze Tian et al.
BLOOD (2014)
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
Apirat Chaikuad et al.
NATURE CHEMICAL BIOLOGY (2014)
Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs
Joerg Hackermueller et al.
GENOME BIOLOGY (2014)
Synergistic Inhibition of Angiogenesis by Artesunate and Captopril In Vitro and In Vivo
Benjamin Krusche et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
NHERF-2 maintains endothelial homeostasis
Resham Bhattacharya et al.
BLOOD (2012)
Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
Wiem Lassoued et al.
CANCER BIOLOGY & THERAPY (2010)
Network models for molecular kinetics and their initial applications to human health
Gregory R. Bowman et al.
CELL RESEARCH (2010)
Genetic Demonstration of a Redundant Role of Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Mitogen-Activated Protein Kinases in Promoting Fibroblast Proliferation
Laure Voisin et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy
Jeong Hun Kim et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Influence of Borneol on In Vitro Corneal Permeability and on In Vivo and In Vitro Corneal Toxicity
H. Yang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
cAMP-mediated Induction of Cyclin E Sensitizes Growth-arrested Adipose Stem Cells to DNA Damage-induced Apoptosis
Hege Ugland et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
What tangled webs they weave: Rho-GTPase control of angiogenesis
B. A. Bryan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Live cell imaging of ERK and MEK
WR Burack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice
Y Sakurai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model
RRJ De Groot-Besseling et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril
JR Merchan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Share Paper
